OpenAI Takes on Google With New AI Model Aimed at Drug Discovery
OpenAI is rolling out an early version of an artificial intelligence model meant to speed up drug discoveries, joining a field of growing interest for tech companies eager to prove AI can pave the way for more scientific breakthroughs.
Every AI provider tells the same reassuring story: prices per token are falling, models are getting more efficient, and intelligence has never been cheaper to buy. OpenAI recently made the
We knew it was only a matter of time.
For the past twelve months, we have watched a steady rhythm of “China is catching up” stories. DeepSeek wiping a trillion
The agentic AI curve is compressing - fast.
With the release of Claude Sonnet 5, we’re seeing a meaningful shift in where real autonomy becomes economically viable.
But zoom out,
OpenAi just announced three new frontier models. Unfortunately, none of them are for you to use.
That is not a coincidence. It is a signal.
On the OpenAI side, the
